Aposense is a highly innovative Israeli biotechnology company with full capacity research facilities and scientific leadership, headed by the Professor Roger D Kornberg, Nobel Prize Laureate, 2006. Aposense developed a universal platform entitled Molecular Nano-Motors (MNMs) for the delivery of genetic drugs, such as siRNA, into cells based on a novel mechanism of action, utilizing membrane electrical forces.
Fascinated by the fact that every cell harbours its own discrete and strong powerhouse, Aposense developed rationally designed Molecular Nano-Motors, being novel small-molecule chemical entities, capable of “energy mining” from the Internal Membrane Electric Field, and its translation into kinetic energy, for movement within the hydrophobic membrane core.
Platform technology extending widely beyond the Liver, unlocking novel targets for genetic therapeutics.
SirVir to present at the Biotech showcase in San Francisco (January 10-12 , 2021)
Aposense and Bioasis Technologies Inc. Enter into a Research Collaboration
SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment